For example, PI3K is activated by EGFR in lung cancers harboring somatic activating mutations in EGFR, and by human epidermal growth factor receptor 2 (HER2) in breast cancers with HER2 amplification [29,32,33]. This evidence concerns the gene ERBB2 and breast cancer.